{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T03:31:09Z","timestamp":1773804669143,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-025-08161-w","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T03:20:16Z","timestamp":1756956016000},"page":"1705-1717","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Endometrial thickness and pathology in postmenopausal women with bleeding on transdermal 17\u03b2-estradiol plus body-identical progesterone"],"prefix":"10.1007","volume":"312","author":[{"given":"Sarah","family":"Glynne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aini","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Neville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynsey","family":"McColl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama","family":"Naji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Newson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Reisel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"issue":"2","key":"8161_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/20533691241254413","volume":"30","author":"K Manley","year":"2024","unstructured":"Manley K et al (2024) Management of unscheduled bleeding on HRT: a joint guideline on behalf of the British Menopause Society, Royal College Obstetricians and Gynaecologists, British Gynaecological Cancer Society, British Society for Gynaecological Endoscopy, Faculty of Sexual and Reproductive Health, Royal College of General Practitioners and Getting it Right First Time. Post Reprod Health 30(2):95\u2013116. https:\/\/doi.org\/10.1177\/20533691241254413","journal-title":"Post Reprod Health"},{"issue":"5","key":"8161_CR2","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/s0015-0282(98)00047-8","volume":"69","author":"B Ettinger","year":"1998","unstructured":"Ettinger B, Li DK, Klein R (1998) Unexpected vaginal bleeding and associated gynecologic care in postmenopausal women using hormone replacement therapy: comparison of cyclic versus continuous combined schedules. Fertil Steril 69(5):865\u2013869. https:\/\/doi.org\/10.1016\/s0015-0282(98)00047-8","journal-title":"Fertil Steril"},{"issue":"6 Pt 2","key":"8161_CR3","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/s0002-9378(89)80006-7","volume":"161","author":"RG Hahn","year":"1989","unstructured":"Hahn RG (1989) Compliance considerations with estrogen replacement: withdrawal bleeding and other factors. Am J Obstet Gynecol 161(6 Pt 2):1854\u20131858. https:\/\/doi.org\/10.1016\/s0002-9378(89)80006-7","journal-title":"Am J Obstet Gynecol"},{"key":"8161_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s44194-024-00038-5","volume":"3","author":"X Ruan","year":"2024","unstructured":"Ruan X, Mueck AO (2024) Criteria for the choice and monitoring of menopausal hormone therapy. Curr Med 3:13. https:\/\/doi.org\/10.1007\/s44194-024-00038-5","journal-title":"Curr Med"},{"issue":"4","key":"8161_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/13697137.2017.1291607","volume":"20","author":"M L\u2019Hermite","year":"2017","unstructured":"L\u2019Hermite M (2017) Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol +\/- progesterone) are optimal. Climacteric 20(4):331\u2013338. https:\/\/doi.org\/10.1080\/13697137.2017.1291607","journal-title":"Climacteric"},{"key":"8161_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000005553","author":"B Levy","year":"2024","unstructured":"Levy B, Simon JA (2024) A contemporary view of menopausal hormone therapy. Obstet Gynecol. https:\/\/doi.org\/10.1097\/AOG.0000000000005553","journal-title":"Obstet Gynecol"},{"issue":"7","key":"8161_CR7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1136\/heartjnl-2019-315898","volume":"106","author":"FL Gersh","year":"2020","unstructured":"Gersh FL, Lavie CJ (2020) Menopause and hormone replacement therapy in the 21st century. Heart 106(7):479\u2013481. https:\/\/doi.org\/10.1136\/heartjnl-2019-315898","journal-title":"Heart"},{"issue":"2","key":"8161_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3109\/13697137.2015.1129166","volume":"19","author":"RJ Baber","year":"2016","unstructured":"Baber RJ et al (2016) 2016 IMS recommendations on women\u2019s midlife health and menopause hormone therapy. Climacteric 19(2):109\u2013150. https:\/\/doi.org\/10.3109\/13697137.2015.1129166","journal-title":"Climacteric"},{"issue":"7","key":"8161_CR9","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1097\/GME.0000000000002028","volume":"29","author":"The North American Menopause Society","year":"2022","unstructured":"The North American Menopause Society (2022) The 2022 hormone therapy position statement of the North American Menopause Society. Menopause 29(7):767\u2013794. https:\/\/doi.org\/10.1097\/GME.0000000000002028","journal-title":"Menopause"},{"issue":"4","key":"8161_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/2053369120957514","volume":"26","author":"H Hamoda","year":"2020","unstructured":"Hamoda H et al (2020) The British Menopause Society & Women\u2019s Health Concern 2020 recommendations on hormone replacement therapy in menopausal women. Post Reprod Health 26(4):181\u2013209. https:\/\/doi.org\/10.1177\/2053369120957514","journal-title":"Post Reprod Health"},{"issue":"2","key":"8161_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/GME.0000000000002459","volume":"32","author":"S Glynne","year":"2025","unstructured":"Glynne S et al (2025) The range and variation in serum estradiol concentration in perimenopausal and postmenopausal women treated with transdermal estradiol in a real-world setting: a cross-sectional study. Menopause 32(2):103\u2013111. https:\/\/doi.org\/10.1097\/GME.0000000000002459","journal-title":"Menopause"},{"key":"8161_CR12","unstructured":"British Menopause Society (2023) Joint BMS FSRH RCGP RCOG SfE and RCN Women\u2019s Health Forum safety alert. https:\/\/thebms.org.uk\/2023\/04\/joint-bms-fsrh-rcgp-rcog-sfe-and-rcn-womens-health-forum-safety-alert\/. Accessed 30 July 2025"},{"issue":"1","key":"8161_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1177\/20533691211058030","volume":"28","author":"H Hamoda","year":"2022","unstructured":"Hamoda H, Medical Advisory Council BMS (2022) British Menopause Society tools for clinicians: progestogens and endometrial protection. Post Reprod Health 28(1):40\u201346. https:\/\/doi.org\/10.1177\/20533691211058030","journal-title":"Post Reprod Health"},{"issue":"4","key":"8161_CR14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1080\/13697137.2016.1187123","volume":"19","author":"P Stute","year":"2016","unstructured":"Stute P, Neulen J, Wildt L (2016) The impact of micronized progesterone on the endometrium: a systematic review. Climacteric 19(4):316\u2013328. https:\/\/doi.org\/10.1080\/13697137.2016.1187123","journal-title":"Climacteric"},{"key":"8161_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2023.101815","author":"P Stute","year":"2023","unstructured":"Stute P et al (2023) Progestogens for endometrial protection in combined menopausal hormone therapy: a systematic review. Best Pract Res Clin Endocrinol Metab. https:\/\/doi.org\/10.1016\/j.beem.2023.101815","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"8161_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/humupd\/3.2.159","volume":"3","author":"N Panay","year":"1997","unstructured":"Panay N, Studd J (1997) Progestogen intolerance and compliance with hormone replacement therapy in menopausal women. Hum Reprod Update 3(2):159\u2013171. https:\/\/doi.org\/10.1093\/humupd\/3.2.159","journal-title":"Hum Reprod Update"},{"issue":"2","key":"8161_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.annonc.2024.10.824","volume":"36","author":"J Kim","year":"2025","unstructured":"Kim J, Munster PN (2025) Estrogens and breast cancer. Ann Oncol 36(2):134\u2013148. https:\/\/doi.org\/10.1016\/j.annonc.2024.10.824","journal-title":"Ann Oncol"},{"issue":"11","key":"8161_CR18","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1210\/jc.2015-2236","volume":"100","author":"CA Stuenkel","year":"2015","unstructured":"Stuenkel CA et al (2015) Treatment of symptoms of the menopause: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 100(11):3975\u20134011. https:\/\/doi.org\/10.1210\/jc.2015-2236","journal-title":"J Clin Endocrinol Metab"},{"key":"8161_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/tog.12553","volume":"21","author":"FG Dave","year":"2019","unstructured":"Dave FG, Adedipe T, Disu S, Laiyemo R (2019) Unscheduled bleeding with hormone replacement therapy. Obstet Gynaecol 21:95\u2013101. https:\/\/doi.org\/10.1111\/tog.12553","journal-title":"Obstet Gynaecol"},{"key":"8161_CR20","unstructured":"Semble. Semble Technology Limited (2024) London, UK. https:\/\/www.semble.io. Accessed 12th August 2024"},{"key":"8161_CR21","unstructured":"Women\u2019s Health Concern.2021 HRT - types, doses and regimens. https:\/\/www.womens-health-concern.org\/wp-content\/uploads\/2022\/11\/27-WHC-FACTSHEET-HRT-Doses-NOV2022-A.pdf. Accessed 30th July 2025"},{"key":"8161_CR22","unstructured":"Electronic medicines compendium (2025) Oestrogel Pump-Pack 750 micrograms\/actuation Gel. Last reviewed https:\/\/www.medicines.org.uk\/emc\/product\/353\/smpc. Accessed 30 July 2025"},{"key":"8161_CR23","unstructured":"Electronic medicines compendium (2025) Evorel 100 Patches. Last reviewed https:\/\/www.medicines.org.uk\/emc\/product\/10932\/smpc. Accessed 30th July 2025"},{"key":"8161_CR24","unstructured":"R Core Team (2024) R: A Language and Environment for Statistical Computing_. R Foundation for Statistical Computing, Vienna, Austria.https:\/\/www.R-project.org\/. Accessed: 5th March 2025"},{"issue":"109","key":"8161_CR25","doi-asserted-by":"publisher","DOI":"10.21105\/joss.07969","volume":"10","author":"D Makowski","year":"2025","unstructured":"Makowski D, Ben-Shachar MS, Wiernik BM, Patil I, Th\u00e9riault R, L\u00fcdecke D (2025) Modelbased: an R package to make the most out of your statistical models through marginal means, marginal effects, and model predictions. J Open Source Softw 10(109):7969. https:\/\/doi.org\/10.21105\/joss.07969","journal-title":"J Open Source Softw"},{"issue":"9","key":"8161_CR26","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1158\/1055-9965.1459.13.9","volume":"13","author":"AS Sit","year":"2004","unstructured":"Sit AS et al (2004) Transvaginal ultrasound measurement of endometrial thickness as a biomarker for estrogen exposure. Cancer Epidemiol Biomarkers Prev 13(9):1459\u20131465","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"8161_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021221","author":"AB Diaz-Ruano","year":"2023","unstructured":"Diaz-Ruano AB et al (2023) Estradiol and estrone have different biological functions to induce Nf-\u039ab-driven inflammation, EMT and stemness in ER+ cancer cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24021221","journal-title":"Int J Mol Sci"},{"issue":"6","key":"8161_CR28","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.cmet.2020.05.008","volume":"31","author":"R Qureshi","year":"2020","unstructured":"Qureshi R et al (2020) The Major pre- and postmenopausal estrogens play opposing roles in obesity-driven mammary inflammation and breast cancer development. Cell Metab 31(6):1154-1172.e9. https:\/\/doi.org\/10.1016\/j.cmet.2020.05.008","journal-title":"Cell Metab"},{"issue":"1","key":"8161_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13058-017-0810-0","volume":"19","author":"H Oh","year":"2017","unstructured":"Oh H et al (2017) Anthropometric measures and serum estrogen metabolism in postmenopausal women: the women\u2019s health initiative observational study. Breast Cancer Res 19(1):28. https:\/\/doi.org\/10.1186\/s13058-017-0810-0","journal-title":"Breast Cancer Res"},{"key":"8161_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082195","author":"CB Tempfer","year":"2020","unstructured":"Tempfer CB et al (2020) Menopausal hormone therapy and risk of endometrial cancer: a systematic review. Cancers. https:\/\/doi.org\/10.3390\/cancers12082195","journal-title":"Cancers"},{"issue":"10333","key":"8161_CR31","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/S0140-6736(22)00323-3","volume":"399","author":"EJ Crosbie","year":"2022","unstructured":"Crosbie EJ et al (2022) Endometrial cancer. Lancet 399(10333):1412\u20131428. https:\/\/doi.org\/10.1016\/S0140-6736(22)00323-3","journal-title":"Lancet"},{"issue":"5","key":"8161_CR32","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/j.1463-1326.2005.00545.x","volume":"8","author":"SR Salpeter","year":"2006","unstructured":"Salpeter SR et al (2006) Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab 8(5):538\u2013554. https:\/\/doi.org\/10.1111\/j.1463-1326.2005.00545.x","journal-title":"Diabetes Obes Metab"},{"issue":"7655","key":"8161_CR33","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1136\/bmj.39555.441944.BE","volume":"336","author":"M Canonico","year":"2008","unstructured":"Canonico M et al (2008) Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ 336(7655):1227\u20131231. https:\/\/doi.org\/10.1136\/bmj.39555.441944.BE","journal-title":"BMJ"},{"issue":"4","key":"8161_CR34","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/13697137.2018.1446931","volume":"21","author":"PY Scarabin","year":"2018","unstructured":"Scarabin PY (2018) Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis. Climacteric 21(4):341\u2013345. https:\/\/doi.org\/10.1080\/13697137.2018.1446931","journal-title":"Climacteric"},{"issue":"6","key":"8161_CR35","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/j.1538-7836.2006.01933.x","volume":"4","author":"M Canonico","year":"2006","unstructured":"Canonico M et al (2006) Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER study. J Thromb Haemost 4(6):1259\u20131265. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.01933.x","journal-title":"J Thromb Haemost"},{"issue":"Suppl 1","key":"8161_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/13697130500148875","volume":"8","author":"H Kuhl","year":"2005","unstructured":"Kuhl H (2005) Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric 8(Suppl 1):3\u201363. https:\/\/doi.org\/10.1080\/13697130500148875","journal-title":"Climacteric"},{"key":"8161_CR37","doi-asserted-by":"publisher","first-page":"115281","DOI":"10.1016\/j.biopha.2023.115281","volume":"166","author":"J Gouju","year":"2023","unstructured":"Gouju J, Legeay S (2023) Pharmacokinetics of obese adults: not only an increase in weight. Biomed Pharmacother 166:115281. https:\/\/doi.org\/10.1016\/j.biopha.2023.115281","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"8161_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004188","volume":"20","author":"D Fitzpatrick","year":"2023","unstructured":"Fitzpatrick D et al (2023) Combined and progestagen-only hormonal contraceptives and breast cancer risk: a UK nested case-control study and meta-analysis. PLoS Med 20(3):e1004188. https:\/\/doi.org\/10.1371\/journal.pmed.1004188","journal-title":"PLoS Med"},{"issue":"18","key":"8161_CR39","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1001\/jama.2024.18575","volume":"332","author":"LS Morch","year":"2024","unstructured":"Morch LS et al (2024) Breast cancer in users of Levonorgestrel-releasing intrauterine systems. JAMA 332(18):1578\u20131580. https:\/\/doi.org\/10.1001\/jama.2024.18575","journal-title":"JAMA"},{"issue":"10","key":"8161_CR40","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/j.1471-0528.1990.tb02447.x","volume":"97","author":"T Garnett","year":"1990","unstructured":"Garnett T et al (1990) Hormone implants and tachyphylaxis. Br J Obstet Gynaecol 97(10):917\u2013921. https:\/\/doi.org\/10.1111\/j.1471-0528.1990.tb02447.x","journal-title":"Br J Obstet Gynaecol"},{"issue":"4","key":"8161_CR41","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1001\/jama.2020.9482","volume":"324","author":"RT Chlebowski","year":"2020","unstructured":"Chlebowski RT et al (2020) Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the women\u2019s health initiative randomized clinical trials. JAMA 324(4):369\u2013380. https:\/\/doi.org\/10.1001\/jama.2020.9482","journal-title":"JAMA"},{"key":"8161_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-024-07307-9","author":"RT Chlebowski","year":"2024","unstructured":"Chlebowski RT et al (2024) Randomized trials of estrogen-alone and breast cancer incidence: a meta-analysis. Breast Cancer Res Treat. https:\/\/doi.org\/10.1007\/s10549-024-07307-9","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"8161_CR43","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/13697137.2017.1421925","volume":"21","author":"P Stute","year":"2018","unstructured":"Stute P, Wildt L, Neulen J (2018) The impact of micronized progesterone on breast cancer risk: a systematic review. Climacteric 21(2):111\u2013122. https:\/\/doi.org\/10.1080\/13697137.2017.1421925","journal-title":"Climacteric"},{"issue":"6","key":"8161_CR44","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1097\/AOG.0000000000004723","volume":"139","author":"HA Abenhaim","year":"2022","unstructured":"Abenhaim HA et al (2022) Menopausal hormone therapy formulation and breast cancer risk. Obstet Gynecol 139(6):1103\u20131110. https:\/\/doi.org\/10.1097\/AOG.0000000000004723","journal-title":"Obstet Gynecol"},{"key":"8161_CR45","doi-asserted-by":"publisher","DOI":"10.1515\/hmbci-2018-0033","author":"AO Mueck","year":"2018","unstructured":"Mueck AO, Romer T (2018) Choice of progestogen for endometrial protection in combination with transdermal estradiol in menopausal women. Horm Mol Biol Clin Investig. https:\/\/doi.org\/10.1515\/hmbci-2018-0033","journal-title":"Horm Mol Biol Clin Investig"},{"key":"8161_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.maturitas.2021.09.002","volume":"154","author":"I Sriprasert","year":"2021","unstructured":"Sriprasert I et al (2021) Use of oral estradiol plus vaginal progesterone in healthy postmenopausal women. Maturitas 154:13\u201319. https:\/\/doi.org\/10.1016\/j.maturitas.2021.09.002","journal-title":"Maturitas"},{"issue":"2","key":"8161_CR47","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/2053369119830822","volume":"25","author":"S Abdullahi Idle","year":"2019","unstructured":"Abdullahi Idle S, Hamoda H (2019) Outcomes of endometrial assessment in women with unscheduled bleeding on hormone replacement therapy. Post Reprod Health 25(2):95\u201399. https:\/\/doi.org\/10.1177\/2053369119830822","journal-title":"Post Reprod Health"},{"issue":"1","key":"8161_CR48","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1258\/mi.2011.011111","volume":"18","author":"N Burbos","year":"2012","unstructured":"Burbos N et al (2012) Postmenopausal vaginal bleeding in women using hormone replacement therapy. Menopause Int 18(1):5\u20139. https:\/\/doi.org\/10.1258\/mi.2011.011111","journal-title":"Menopause Int"},{"key":"8161_CR49","unstructured":"NHS Business Services Authority (2024) Hormone replacement therapy - England, April 2015 to June 2024. https:\/\/cms.nhsbsa.nhs.uk\/statistical-collections\/hormone-replacement-therapy-england\/hormone-replacement-therapy-england-april-2015-june-2024. Accessed 10th February 2025"},{"issue":"2","key":"8161_CR50","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1210\/er.2012-1008","volume":"34","author":"FZ Stanczyk","year":"2013","unstructured":"Stanczyk FZ et al (2013) Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects. Endocr Rev 34(2):171\u2013208. https:\/\/doi.org\/10.1210\/er.2012-1008","journal-title":"Endocr Rev"},{"issue":"4","key":"8161_CR51","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/GME.0000000000000519","volume":"23","author":"L Zhu","year":"2016","unstructured":"Zhu L et al (2016) Effect of hormone therapy on the risk of bone fractures: a systematic review and meta-analysis of randomized controlled trials. Menopause 23(4):461\u2013470. https:\/\/doi.org\/10.1097\/GME.0000000000000519","journal-title":"Menopause"},{"issue":"3","key":"8161_CR52","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/PPO.0000000000000591","volume":"28","author":"HN Hodis","year":"2022","unstructured":"Hodis HN, Mack WJ (2022) Menopausal hormone replacement therapy and reduction of all-cause mortality and cardiovascular disease: it is about time and timing. Cancer J 28(3):208\u2013223. https:\/\/doi.org\/10.1097\/PPO.0000000000000591","journal-title":"Cancer J"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08161-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-025-08161-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08161-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T07:29:23Z","timestamp":1762327763000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-025-08161-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":52,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["8161"],"URL":"https:\/\/doi.org\/10.1007\/s00404-025-08161-w","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,4]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}